García-Lara MÁ, Sánchez-Sagrero A, Aguilar-Águila-Martínez A, López-León NL

Language: Spanish
References: 15
Page: 129-134
PDF size: 267.29 Kb.

ABSTRACT

Knowledge of the pathophysiology of burns is the basis of perioperative management. All organs and systems are altered and hemodynamic changes in the acute phase are characterized by a decrease in cardiac output. After six days of injury a new hemodynamic change occurs, this phase is known as hypermetabolic state and its duration is in relation to the extent and depth of the injury. Inhalation injury is an important factor to consider as a poor prognosis and also the number of associated comorbidities and/or trauma. During this second period the Anesthesiologists have a continuous and close participation. Pharmacological problems, airway management, vascular access, hypothermia, monitoring and pain control among others become very marked. Finally, the phase of sequelae is for life and the magnitude of damages, costs and disability will be directly related to the care administered during the first two phases.

REFERENCES

1. Moctezuma PL, Páez FI, Jiménez GS, Miguel HK, Foncerrada OG, Sánchez A y cols. Epidemiología de las quemaduras en México. Rev Esp Méd Quir. 2015;20:78-82.

2. Latenser BA. Critical care of the burn patient: the first 48 hours. Crit Care Med. 2009;37:2819-2826.

3. Jewo PI, Fadeyibi IO. Progress in burns research: a review of advances in burn pathopysiology. Ann Burns Fire Disasters. 2015;28:105-115.

4. Bittner EA, Shank E, Woodson L, Martyn JA. Acute and perioperative care of the burn-injured patient. Anesthesiology. 2015;122:448-464.

5. Spano S, Hanna S, Li Z, Wood D, Cartotto R. Does bronchoscopic evaluation of inhalation injury severity predict outcome? J Burn Care Res. 2016;37:1-11.

6. Thombs BD, Singh VA, Halonen J, Diallo A, Milner SM. The effects of preexisting medical comorbidities on mortality an length of hospital stay and acute burn injury. Ann Surg 2007;245:629-634.

7. Diaz EC, Herdon DN, Porter C, Sidossis LS, Suman OE, Borsheim E. Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns. Burns. 2015;41:649-657.

8. Rojas Y, Finnerty CC, Radhakrishnan RS, Herdon DN. Burns: an update on current pharmacotherapy. Expert Opin Pharmacother. 2012;13:2485-2494.

9. Woodson L, Sherwood E, Aarsland A, Talon M, Kinsky MP, Morvant EM. Anesthesia for burned patients. In: Herndon DN. Total burn care. 4th. ed., Edinburgh: Saunders Elsevier, 2012, pp. 173-205.

10. Schmitz B, Griswold J. Airway management in burn patients. In: Hagberg C. Benumof's and Hagberg's airway management. Philadelphia : Elsevier/Saunders, 3rd. ed., 2013, pp. 902-911.

11. García LM. Vía aérea difícil del paciente gran quemado y con secuelas de quemaduras. Rev Mex Anest. 2014;37:S222-S225.

12. Kramer G. Pathopysiology of burn shock and burn edema. In: Herdon D. Total burn care. Edinburgh: Saunders Elsevier, 4th. ed., 2012, pp. 104-117.

13. Romanowski K, Palmieri TI, Sen S, Greenhalgh DG. More than one third of intubations in patients transferred to burn centers are unnecessary: proposed guidelines for appropriate intubation of the burn patient. Burn Care Res. 2016;37:e409-e414.

14. Blanchet B, Jullien V, Vinsonneau C, Tod M. Influence of burns on pharmacokinetics and parmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet. 2008;47:635-654.

15. García LM. Manejo de líquidos en el perioperatorio del paciente quemado. Rev Mex Anest. 2015;38:S230-S233.